AVUGANE Trademark

Trademark Overview

On Friday, June 2, 2006, a trademark application was filed for AVUGANE with the United States Patent and Trademark Office. The USPTO has given the AVUGANE trademark a serial number of 79025622. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, June 2, 2016. This trademark is owned by TOPOTARGET A/S. The AVUGANE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of skin disorders; chemical preparations and reagents for medical use
avugane

General Information

Serial Number79025622
Word MarkAVUGANE
Filing DateFriday, June 2, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, June 2, 2016
Registration Number3258957
Registration DateTuesday, July 3, 2007
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 17, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of skin disorders; chemical preparations and reagents for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 7, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTOPOTARGET A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCopenhagen DK2100
DK
Party NameTOPOTARGET A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCopenhagen DK2100
DK
Party NameTOPOTARGET A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCopenhagen DK2100
DK

Trademark Events

Event DateEvent Description
Friday, December 30, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, December 30, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, June 12, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Sunday, April 12, 2015GENERIC MADRID TRANSACTION SENT TO IB
Sunday, April 12, 2015GENERIC MADRID TRANSACTION CREATED
Tuesday, October 7, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 7, 2014CANCELLED SECTION 71
Friday, September 19, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, November 14, 2007FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, November 14, 2007FINAL DISPOSITION PROCESSED
Wednesday, November 7, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 3, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, April 17, 2007PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2007NOTICE OF PUBLICATION
Wednesday, February 28, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 28, 2007ASSIGNED TO LIE
Wednesday, January 24, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 23, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 22, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 22, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 17, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 17, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 24, 2006REFUSAL PROCESSED BY IB
Monday, November 6, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 6, 2006REFUSAL PROCESSED BY MPU
Saturday, November 4, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 3, 2006NON-FINAL ACTION WRITTEN
Thursday, November 2, 2006ASSIGNED TO EXAMINER
Friday, August 11, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, August 10, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

avugane preparations chemical reagents medical disorders skin treatment prevention pharmaceutical